Centrica announces Senior Independent Director Kevin O’Byrne as Chair-designate

– UK, Windsor –  Centrica plc (LON: CNA) announced the appointment of current Senior Independent Director Kevin O’Byrne as Chair-designate to succeed Scott Wheway who will step down from the Board on 16 December 2024.

Kevin O’Byrne, Senior Independent Director and Chair Designate said: “I am honoured and excited to take on the role of Chair at Centrica. I look forward to building on the strong foundations Scott has laid over his time as Chair, and to working with the Board, Chris and the executive team to execute the Company’s strategy and deliver material value for all our stakeholders”.

About Kevin O’Byrne

Kevin O’Byrne brings extensive executive and Board experience, in addition to knowledge of Centrica’s operations, to the role. He has significant experience in complex financial and capital allocation decision-making matters. Kevin has held CFO and CEO roles in several leading UK and international retailers since 2004, including Chief Financial Officer of J Sainsbury plc from 2017 to 2023. He was previously an executive director of Kingfisher plc and Dixons Retail plc. He was a non-executive director of Land Securities plc from 2008 to 2017 where he was Chair of the Audit Committee and Senior Independent Director. Kevin is currently also a non-executive director of NYSE-listed International Flavors & Fragrances Inc., a multinational market-leading supplier to the food, beverage, beauty, and household and personal care sectors. At IFF he is Chair of the Governance & Corporate Responsibility Committee and sits on the Innovation and Audit Committees.

For more: https://www.centrica.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.